The FDA granted clearance to Aidoc for an AI-powered triage tool capable of detecting 14 acute conditions from CT scans.
The tool combines 11 newly cleared and three previously cleared indications into a single workflow, making it the first FDA-cleared set of double-digit acute findings supported by a foundation model, according to a Jan. 21 company news release. Aidoc said the tool is designed to improve patient flow by surfacing critical findings earlier amid emergency department crowding and imaging backlogs.
In FDA-reviewed testing, the tool correctly identified urgent conditions in nearly all cases and produced far fewer false alarms than older, single-use AI tools. The system has analyzed more than 100 million patient cases.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
